IPSOS
Ipsos completes the acquisition of The BVA Family
Ipsos completes the acquisition of The BVA Family
Ipsos completes the acquisition of The BVA Family
Paris, 24 June 2025 - Ipsos, one of the world's leading market research companies, has completed the acquisition of The BVA Family.
The operation was concluded after fulfilling all necessary regulatory requirements, including in-depth consultation with employee representatives in France and obtaining relevant competition authority approvals.
This acquisition is a significant expansion for Ipsos in France and adds new strength in the UK and Italy. BVA notably brings its recognized expertise in customer experience monitoring, point-of-sale behavior analysis, and research for government and public services. The company also boasts research methodologies that focus on behavioral sciences. Its expertise in pack testing through PRS IN VIVO is a key global strength that can now be rolled out across a much larger geographic footprint by Ipsos.
Ben Page, CEO of Ipsos, stated: “We are delighted to welcome The BVA Family teams to Ipsos. They now benefit from our global infrastructure, and the opportunities our scale brings them, while our clients will have access to new, innovative solutions. With our strong cultural fit and complementary set of services, we are poised to deliver even greater value to the businesses and organizations we serve.”
Gerard Lopez and Pascal Gaudin, Chairmen of The BVA Family, added: “We are pleased to join forces with Ipsos, one of the world leaders in market research. This partnership allows us to leverage its international presence and solid competencies, significantly enhancing our capabilities to provide cutting-edge analysis and understanding of society and markets to our clients.”
Ipsos France will now operate under the name Ipsos Bva, while the teams in Italy will use the name Ipsos Doxa. In the UK, BDRC will operate under the Ipsos brand.
ABOUT IPSOS
Ipsos is one of the largest market research and polling companies globally, operating in 90 markets and employing nearly 20,000 people.
Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 business solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques.
“Game Changers” – our tagline – summarizes our ambition to help our 5,000 clients navigate with confidence our rapidly changing world.
Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120, Mid-60 indices and is eligible for the Deferred Settlement Service (SRD).
ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP
www.ipsos.com
35 rue du Val de Marne
75 628 Paris, Cedex 13 France
Tel. +33 1 41 98 90 00
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Giga Metals Corporation24.6.2025 22:29:34 CEST | Press release
Scott Lendrum appointed Chief Executive Officer of Giga Metals Corporation
Cellebrite DI Ltd24.6.2025 22:01:00 CEST | Press release
Accelerating Child Exploitation Investigations: Cellebrite Integrates Data from the National Center for Missing and Exploited Children (NCMEC)
Carestream Health24.6.2025 20:56:41 CEST | Press release
Carestream Demonstrates Commitment to Sustainability with Better Stands Silver Award at Hospitalar 2025
Arcoma AB24.6.2025 19:15:24 CEST | Press release
Arcoma AB successfully completes directed share issue of SEK 11.0 million (~ EUR 1 million) (MAR)
FastPassCorp A/S24.6.2025 18:57:13 CEST | Press release
FN6/2025 Forventningerne til ARR hæves efter rekordhøj vækst i første halvår
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom